Skip to content

A multi-part study to investigate MTX325 in healthy volunteers and patients with Parkinson's Disease

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-517310-15-00
Enrollment
12
Registered
2026-05-18
Start date
Unknown
Completion date
Unknown
Last updated
2026-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's Disease

Interventions

None listed

Sponsors

Mission Therapeutics Limited
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Outcome results

None listed

Source: EU CTIS · Data processed: May 20, 2026